PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 2,865.00
-5.00 (-0.17%)
Nov 4, 2026, 3:30 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 64.78 billion as of November 4, 2026. It is the 30,268th most valuable company in the world and the 1,574th biggest in South Korea. Its market cap has decreased by 11.30% in one year.
Market Cap
64.78B
Enterprise Value
70.13B
Revenue
171.66B
Global Rank
Country Rank
#1,574 South Korea
PE Ratio
440.99
ChartMarket Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 64.78B, an increase of 494.80%. That is a compound annual growth rate of 5.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 64.78B | -28.84% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 67.14T |
| Celltrion | 43.38T |
| ALTEOGEN | 14.86T |
| Samsung Epis Holdings | 7.59T |
| Ray Co., Ltd. | 65.38B |
| Access Bio | 64.65B |
| DK Life Science | 64.45B |
| Amicogen | 64.25B |